Skip to main content
OpenTrials

Clinical trial condition

Oligodendroglioma

Explore clinical trials studying Oligodendroglioma. Study availability and eligibility vary by location and protocol.

299 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Oligodendroglioma trial results

Completed

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

NCT00017264

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Karenitecin in Treating Patients With Recurrent Malignant Glioma

NCT00014521

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide

NCT00717210

Conditions
Anaplastic Astrocytoma, Astrocytoma, Glioma, +9 more
Locations
  • University of Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Neurology and Radiotherapy Tübingen, Baden-Wurttemberg, Germany
  • Klinikum Aschaffenburg Aschaffenburg, Germany
  • Nervenklinik Bamberg, Germany
View Trial Details
Active, Not Recruiting

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NCT03180502

Conditions
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Emory Proton Therapy Center Atlanta, Georgia, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

NCT03220646

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only) Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Pediatric Long-Term Follow-up and Rollover Study

NCT03975829

Conditions
Anaplastic Astrocytoma, Anaplastic Ganglioglioma, Anaplastic Oligodendroglioma, +62 more
Locations
  • Phoenix Children s Hospital Phoenix, Arizona, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • Nicklaus Childrens Hospital Miami, Florida, United States
  • Indiana Uni School of Medicine Indianapolis, Indiana, United States
View all 55 locations
View Trial Details
Active, Not Recruiting

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

NCT00268385

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

NCT04978727

Conditions
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Washington D.C., District of Columbia, United States
View all 14 locations
View Trial Details

Related conditions